// App-Quantinova.ai

TCT CONNECT-58 : Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Researchers

Presenter

  • Deepak Bhatt

Principal Investigators

  • Philippe Gabriel Steg

  • Jonas Oldgren

  • Michael Maeng

  • Uwe Zeymer

  • Sigrun Halvorsen

  • Stefan Hohnloser

  • Gregory Lip

  • Takeshi Kimura

  • Matias Nordaby

  • Miede Corinna

  • Jurrien Ten Berg

  • Christopher Cannon

  • Benjamin Peterson

Medical Centers

  • Brigham and Women's Hospital, Boston, Massachusetts

  • Aarhus University Hospital, Aarhus, Denmark

  • University of Birmingham, Birmingham, United Kingdom

  • Herzzentrum Ludwigshafen, Ludwigshafen, Germany

  • Johann Wolfgang Goethe-University, Frankfurt, Germany.

  • Boehringer Ingelheim International, Ingelheim, Germany

  • Kyoto University Hospital, Kyoto, Japan

  • Hopital Bichat, Paris, France

  • Department of Oncology, Oslo University Hospital and University of Oslo, Oslo, Norway

  • St Antonius Hospital, Nieuwegein, Netherlands

  • Uppsala University Hospital, Uppsala, Sweden

Locations

  • United States

  • Japan

  • Denmark

  • Germany

  • France

  • United Kingdom

  • Norway

  • Netherlands

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Warfarin

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved